GlaxoSmithKline PLC — Director's Dealing 2016

Aug 16, 2016

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 3430H

GlaxoSmithKline PLC

16 August 2016

GlaxoSmithKline plc (the 'Company')

Transaction notification

1.

Details of PDMR/person closely associated with them ('PCA')

a)

Name

Dr M M Slaoui

b)

Position/status

Chairman, Global Vaccines

c)

Initial notification/

amendment

Initial notification

2.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

GlaxoSmithKline plc

b)

LEI

5493000HZTVUYLO1D793

3.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted

a)

Description of the financial  instrument

American Depositary Shares ('ADSs')

ISIN: US37733W1053

b)

Nature of the transaction

An increase of 14 ADS following the notional allocation of ADSs on 12 August 2016, at a price of $44.17 per ADS, as a result of the revaluation of the cash element of the notional investment held within the GSK 401(K) plan.

c)

Price(s) and volume(s)

Price(s)	Volume(s)
$44.17	14

d)

Aggregated information

Aggregated volume Price

n/a (single transaction)

e)

Date of the transaction

2016-08-12

f)

Place of the transaction

n/a

1.

Details of PDMR/person closely associated with them ('PCA')

a)

Name

Dr K Slaoui

b)

Position/status

PCA of Dr M M Slaoui (Chairman, Global Vaccines)

c)

Initial notification/

amendment

Initial notification

2.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

GlaxoSmithKline plc

b)

LEI

5493000HZTVUYLO1D793

3.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted

a)

Description of the financial  instrument

GlaxoSmithKline plc American Depositary Shares ('ADSs')

ISIN: US37733W1053 

b)

Nature of the transaction

An increase of 2 ADS following the notional allocation of ADSs on 12 August 2016, at a price of $44.17 per ADS, as a result of the revaluation of the cash element of the notional investment held within the GSK 401(K) plan.

c)

Price(s) and volume(s)

Price(s)	Volume(s)
$44.17	2

d)

Aggregated information

Aggregated volume Price

n/a (single transaction)

e)

Date of the transaction

2016-08-12

f)

Place of the transaction

n/a

This information is provided by RNS

The company news service from the London Stock Exchange

END

DSHZQLFFQVFBBBQ

//<![CDATA[$.ajaxSetup({headers: {'__RequestVerificationToken':'5S3B1cT_HMbBGb8vALlqHpPITw0rpRTONr6D3rEtB9oT0UQ7q67G1Tt5jDvhLrpcD9iAM8mTiYOKks4FLbkE-qAkJzlTMGgCV6nojlxwzjc1:QR267JcDrOmCmfXs_gTRl_Ge3gtAO0pUCQu8I6-62XXrBfXpg7u2lms_4HN8hZEobCspA2O2V8O--fAtQ6xqDk2ni07PYdkcyDKPhWLYhqI1'}});//]]>